Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Veristat Blog

Monthly FDA Guidance and Regulatory News Review - August 2026

This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal...

Monthly FDA Guidance and Regulatory News Review - July 2026

This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses...

Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion

China is rapidly becoming one of the most influential forces in global drug development—but...

Life Sciences Today Podcast: Using AI to Reduce Biostatistical Analysis Readouts

AI is changing clinical development, but speed alone isn't enough. In a regulated industry, every...

Monthly FDA Guidance and Regulatory News Review - June 2026

This June 2026 regulatory update focuses on advancing innovative drug development through updated...

ASCO 2026: ADCs Are Redefining What Targeted Therapy Can Do

Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a...

Authoring & Assembling IND and CTA Applications

Investigational New Drug Applications (INDs) and Clinical Trial Applications (CTAs) are regulatory...

What is a Scientific & Medical Publications Professional?

Would your drug development program benefit from partnering with experts in scientific and medical...